Literature DB >> 3284397

Spindle-cell proliferations of the urinary tract. An immunohistochemical study.

M R Wick1, B A Brown, R H Young, S E Mills.   

Abstract

In order to define the immunohistochemical features of spindle cell proliferations of the urinary tract, we studied 18 lesions of this type with a panel of antibodies to epithelial and mesenchymal determinants. Histologically, 13 cases showed features that were not conclusively those of either spindle cell carcinoma or sarcoma, three contained overtly epithelial areas, and two were classified as "postoperative spindle cell nodules" (PSCN). Nine tumors in the indeterminate group and three with focally overt carcinomatous growth stained for cytokeratin and epithelial membrane antigen (EMA) and were classified as carcinomas. Eleven of these coexpressed vimentin, but desmin and muscle-specific actin were undetectable. The four remaining indeterminate neoplasms expressed desmin and muscle-specific actin as well as vimentin, but they lacked epithelial markers; these were categorized as leiomyosarcomas. Both PSCN were reactive for cytokeratin with each of three separate monoclonal antibody preparations. Desmin, actin, and vimentin were also observed in such lesions, but EMA was not. Because spindle cell proliferations may be difficult to interpret in routinely stained tissue sections, the additional information provided by immunohistochemical studies is helpful in establishing a diagnosis and separating biologically disparate lesions.

Entities:  

Mesh:

Year:  1988        PMID: 3284397     DOI: 10.1097/00000478-198805000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Primary undifferentiated spindle-cell carcinoma of the gallbladder presenting as a liver tumor.

Authors:  Tomotaka Akatsu; Masakazu Ueda; Motohide Shimazu; Go Wakabayashi; Koichi Aiura; Minoru Tanabe; Shigeyuki Kawachi; Kaori Kameyama; Masaki Kitajima
Journal:  J Gastroenterol       Date:  2005-10       Impact factor: 7.527

2.  Comparative immunohistochemistry of malignant fibrous histiocytoma and sarcomatoid carcinoma of the urinary tract.

Authors:  Y Hasui; S Nishi; S Kitada; Y Osada; A Sumiyoshi
Journal:  Urol Res       Date:  1991

3.  Myocbacterium-avium intracellulare associated inflammatory pseudotumor of the anterior nasal cavity.

Authors:  Sadaf Ilyas; Dima Youssef; Humera Chaudhary; Mousa A Al-Abbadi
Journal:  Head Neck Pathol       Date:  2011-02-16

4.  Sarcomatoid carcinoma of the prostate: a case report.

Authors:  Adamantia Zizi-Sermpetzoglou; Vassiliki Savvaidou; Nikolaos Tepelenis; Nikolaos Galariotis; Michalis Olympitis; Konstantinos Stamatiou
Journal:  Int J Clin Exp Pathol       Date:  2010-02-05

5.  Immunohistochemical study of sarcoma-like mural nodules in a mucinous cystadenocarcinoma of the ovary.

Authors:  X Matias-Guiu; I Aranda; J Prat
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 6.  Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.

Authors:  Thomas Nelius; J Stevens; C Samathanam; S Filleur
Journal:  Med Oncol       Date:  2009-06-11       Impact factor: 3.064

7.  Clinical features of sarcomatoid carcinoma (carcinosarcoma) of the urinary bladder: analysis of 221 cases.

Authors:  Jue Wang; Fen Wei Wang; Chad A Lagrange; George P Hemstreet Iii; Anne Kessinger
Journal:  Sarcoma       Date:  2010-07-18

Review 8.  [Mesenchymal tumors of the urinary bladder].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-02       Impact factor: 1.011

9.  Carcinosarcoma of the urinary bladder: a distinct variant characterized by small cell undifferentiated carcinoma with neuroendocrine features.

Authors:  L Mazzucchelli; R Kraft; H Gerber; C Egger; U E Studer; A Zimmermann
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

10.  Postoperative spindle cell nodule of the bladder: A case report and review of the literature.

Authors:  Jiyu Zhao; Hao Ping; Nianzeng Xing
Journal:  Oncol Lett       Date:  2014-02-28       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.